AssetMark Inc’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.81M | Buy |
31,076
+5,479
| +21% | +$503K | 0.01% | 802 |
|
|
2025
Q4 | $2.3M | Buy |
25,597
+4,955
| +24% | +$470K | ﹤0.01% | 828 |
|
|
2025
Q3 | $2.03M | Buy |
20,642
+4,188
| +25% | +$415K | ﹤0.01% | 807 |
|
|
2025
Q2 | $1.5M | Buy |
16,454
+7,462
| +83% | +$722K | ﹤0.01% | 834 |
|
|
2025
Q1 | $1.02M | Buy |
8,992
+2,491
| +38% | +$266K | ﹤0.01% | 863 |
|
|
2024
Q4 | $687K | Sell |
6,501
-13,640
| -68% | -$1.46M | ﹤0.01% | 910 |
|
|
2024
Q3 | $2.17M | Sell |
20,141
-6,798
| -25% | -$742K | 0.01% | 630 |
|
|
2024
Q2 | $2.92M | Buy |
26,939
+2,864
| +12% | +$338K | 0.01% | 529 |
|
|
2024
Q1 | $3.18M | Sell |
24,075
-11,690
| -33% | -$1.46M | 0.01% | 499 |
|
|
2023
Q4 | $4.35M | Buy |
35,765
+1,280
| +4% | +$143K | 0.02% | 399 |
|
|
2023
Q3 | $3.87M | Sell |
34,485
-1,518
| -4% | -$193K | 0.02% | 389 |
|
|
2023
Q2 | $5.24M | Sell |
36,003
-52
| -0.1% | -$7.07K | 0.02% | 335 |
|
|
2023
Q1 | $4.66M | Buy |
36,055
+2,467
| +7% | +$310K | 0.02% | 322 |
|
|
2022
Q4 | $4.28M | Buy |
33,588
+11,414
| +51% | +$1.32M | 0.02% | 319 |
|
|
2022
Q3 | $2.32M | Buy |
22,174
+7,621
| +52% | +$836K | 0.01% | 364 |
|
|
2022
Q2 | $1.53M | Buy |
14,553
+10,327
| +244% | +$1.23M | 0.01% | 410 |
|
|
2022
Q1 | $541K | Buy |
4,226
+2,185
| +107% | +$263K | ﹤0.01% | 608 |
|
|
2021
Q4 | $252K | Buy |
2,041
+1,600
| +363% | +$209K | ﹤0.01% | 658 |
|
|
2021
Q3 | $63K | Buy |
441
+173
| +65% | +$25.4K | ﹤0.01% | 745 |
|
|
2021
Q2 | $42K | Sell |
268
-163
| -38% | -$26.4K | ﹤0.01% | 777 |
|
|
2021
Q1 | $67K | Sell |
431
-126
| -23% | -$19.5K | ﹤0.01% | 687 |
|
|
2020
Q4 | $83K | Buy |
557
+156
| +39% | +$22K | ﹤0.01% | 637 |
|
|
2020
Q3 | $53K | Buy |
401
+39
| +11% | +$5.09K | ﹤0.01% | 663 |
|
|
2020
Q2 | $42K | Sell |
362
-10,620
| -97% | -$1.22M | ﹤0.01% | 681 |
|
|
2020
Q1 | $1.08M | Buy |
10,982
+9,908
| +923% | +$1.3M | 0.01% | 310 |
|
|
2019
Q4 | $156K | Sell |
1,074
-24
| -2% | -$3.31K | ﹤0.01% | 567 |
|
|
2019
Q3 | $146K | Sell |
1,098
-474
| -30% | -$61.2K | ﹤0.01% | 549 |
|
|
2019
Q2 | $180K | Sell |
1,572
-259
| -14% | -$30.3K | ﹤0.01% | 483 |
|
|
2019
Q1 | $227K | Sell |
1,831
-16
| -0.9% | -$1.82K | ﹤0.01% | 436 |
|
|
2018
Q4 | $186K | Buy |
1,847
+1,603
| +657% | +$180K | ﹤0.01% | 453 |
|
|
2018
Q3 | $31K | Sell |
244
-177
| -42% | -$21K | ﹤0.01% | 843 |
|
|
2018
Q2 | $46K | Sell |
421
-46
| -10% | -$5.01K | ﹤0.01% | 738 |
|
|
2018
Q1 | $49K | Sell |
467
-183
| -28% | -$21.3K | ﹤0.01% | 741 |
|
|
2017
Q4 | $76K | Buy |
650
+105
| +19% | +$11.9K | ﹤0.01% | 675 |
|
|
2017
Q3 | $62K | Buy |
545
+34
| +7% | +$3.92K | ﹤0.01% | 654 |
|
|
2017
Q2 | $64K | Sell |
511
-36
| -7% | -$4.27K | ﹤0.01% | 628 |
|
|
2017
Q1 | $65K | Sell |
547
-4
| -0.7% | -$453 | ﹤0.01% | 588 |
|
|
2016
Q4 | $55K | Buy |
551
+35
| +7% | +$3.75K | ﹤0.01% | 597 |
|
|
2016
Q3 | $65K | Buy |
516
+114
| +28% | +$14.1K | ﹤0.01% | 563 |
|
|
2016
Q2 | $47K | Buy |
402
+34
| +9% | +$3.85K | ﹤0.01% | 624 |
|
|
2016
Q1 | $38K | Buy |
368
+48
| +15% | +$4.64K | ﹤0.01% | 628 |
|
|
2015
Q4 | $32K | Buy |
320
+319
| +31,900% | +$31.2K | ﹤0.01% | 713 |
|
|
2015
Q3 | $0 | Sell |
1
-18,962
| -100% | -$1.9M | ﹤0.01% | 865 |
|
|
2015
Q2 | $2.01M | Buy |
+18,963
| New | +$2.1M | 0.04% | 192 |
|
Other funds holding ZBH
VCM
VPM
AssetMark Inc's ZBH Position: Q1 2026 in Review
AssetMark Inc increased its Zimmer Biomet (ZBH) stake by 21% in Q1 2026, buying an estimated $503K and bringing the position to 31,076 shares worth $2.81M. The position accounts for 0.01% of the portfolio, ranked #802.
AssetMark Inc first reported a position in ZBH in Q2 2015 and has held it in 44 quarters since. The position peaked at $5.24M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- AssetMark Inc held 31,076 shares of Zimmer Biomet worth $2.81M as of Q1 2026.
- AssetMark Inc bought 5,479 Zimmer Biomet shares in Q1 2026, an estimated $503K.
- Zimmer Biomet made up 0.01% of AssetMark Inc's portfolio in Q1 2026, its #802 holding.
- AssetMark Inc first reported a position in Zimmer Biomet in Q2 2015 and has held it in 44 quarters since.
- AssetMark Inc's Zimmer Biomet position peaked at $5.24M in Q2 2023.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on AssetMark Inc's 13F filing for Q1 2026, filed 6 May 2026.